Keeping Track Of The US FDA's Final Approvals Of 2018
Executive SummaryA roundup of the US FDA's drug approvals in the final weeks of 2018.
You may also be interested in...
Novel antifungal T-2307, discovered by FUJIFILM Toyama, works by selectively disrupting mitochondrial function. Excelra and Maruho team up to repurpose existing drugs.
The latest drug development news and highlights from our US FDA Performance Tracker.
Public Company Edition: The prior day's after-hours bad news sent biotech stocks lower on 9 August, and IPOs are taking a breather with the NBI down 2.1% over the past month. However, already public companies are raising cash, including Allakos and Ironwood at $350m each.